Agilent Technologies Awards Microarray Prize to Dutch Scientist for Research on Tumor Suppressor Genes
Dr. Kok's winning entry combines array-based comparative genomic hybridization (aCGH) with traditional gene-expression profiling in the search for novel tumor suppressor (TS) genes implicated in conventional renal cell carcinoma (cRCC). Nearly 100 teams entered the contest, which ran from November 2006 through January 2007.
"We congratulate Dr. Kok and are pleased to be supporting his research, which could have broad implications across many cancers involving tumor suppressor mechanisms," said Linda Roettger, marketing manager, Agilent Life Sciences Solutions Unit.
Organizations
Other news from the department research and development
Get the chemical industry in your inbox
From now on, don't miss a thing: Our newsletter for the chemical industry, analytics, lab technology and process engineering brings you up to date every Tuesday and Thursday. The latest industry news, product highlights and innovations - compact and easy to understand in your inbox. Researched by us so you don't have to.